Bioengineering Center

The Bioengineering Center combines interdisciplinary skills from natural sciences, engineering, and medicine to invent, innovate, and advance technological solutions that enable individualized precision measurements and processing of biological information for the promotion of healthcare. 

The Bioengineering Center combines interdisciplinary skills from natural sciences, engineering, and medicine to invent, innovate, and advance technological solutions that enable individualized precision measurements and processing of biological information for the promotion of healthcare. 

Collage of bright neon circuit lights in direct stream and big data circle

Our Research Areas

mouse body with cancer

Novel Biomedical Readouts

We enable novel biomedical readouts by reshaping next-generation hardware and theoretical and algorithmic developments for sensors, imaging and microscopy and by engineering biological contrast using genetically expressed chromo proteins and genetic labels.

IBMI_Slider_01_Zebrafish2

Discovery and Validation

We accelerate discovery and validation by employing advanced observation tools for in vivo sensing, imaging, omics and single-cell processing, with a focus on combining dynamic observations in living systems with functional genomics.

IBMI_Slider_03_RSOM_skin

Clinical Translation

We advance prevention of disease, early detection, advanced diagnostics, improved intervention, and precise therapy monitoring by efficiently translating advanced sensors and imaging systems technology toward clinical use.

Our Mission

Bioengineering Banner Topic

Discover Our Topics

Follow the link to explore our vision and key topics. 

Read more

News

See all
Helmholtz Biomedical Engineering Initiative

AI, Transfer, Bioengineering, IBMI, Pioneer Campus,

Helmholtz Biomedical Engineering Initiative: Shaping the Future of Health

The Helmholtz Association is launching a nationwide biomedical engineering initiative to accelerate technology development and transfer activities. Led by its established Health Centers, “Helmholtz Biomedical Engineering” brings together cutting-edge…

Intricate network of red capillaries, a detailed view of microscopic blood vessels conveying vitality

New Research Findings, Bioengineering, IBMI,

New Imaging Technology Detects Early Signs of Heart Disease Through the Skin

Researchers from Helmholtz Munich and the Technical University of Munich (TUM) have developed “fast-RSOM”, a new imaging technology that can capture detailed images of the smallest blood vessels directly through the skin – without the need for…

A dynamic web of entities and people working together to foster and advance new ideas, technologies, and solutions.

Transfer, Bioengineering, IBMI, Pioneer Campus,

From Lab Bench to Startup: New Doctorate Program Offers Scientists a Venture-Building Path

Helmholtz Munich is partnering with Deep Science Ventures (DSV) and SPRIND, Germany’s Federal Agency for Disruptive Innovation, to support the Venture Science Doctorate (VSD) – a novel doctoral program designed to train scientists to build…

Esophageal Cancer

New Research Findings, Bioengineering, IBMI,

New Endoscopy Technology Enables Early Detection of Esophageal Cancer

Researchers from Helmholtz Munich, the Technical University of Munich (TUM), and the Medical University of Vienna have developed an advanced imaging technique called "O2E" that allows clinics to detect cancerous lesions in the esophagus with…

A vibrant abstract composition shows interconnected blue dots and lines in a dark environment

Awards & Grants, Computational Health, ICB, Bioengineering, IBMI, Molecular Targets and Therapeutics, MCD,

Three ERC Proof of Concept Grants for Helmholtz Munich

Researchers at Helmholtz Munich have secured three prestigious Proof of Concept Grants from the European Research Council (ERC). This funding will enable them to advance innovative projects across diverse areas of biomedical research. With a total of…

Multiple Myeloma

New Research Findings, Bioengineering, IBMI,

New Label-Free Imaging Tracks Cancer Treatment in Single Cells

Researchers from Helmholtz Munich and the Technical University of Munich have developed a novel method to track cancer treatment responses in individual cells – without the need for dyes or labels. Their mid-infrared optoacoustic microscopy (MiROM)…

Recent Publications

Photoacoustics 47:100793 (2026)

Fasoula, N.-A. ; Katsouli, N. ; Kallmayer, M. ; Ntziachristos, V. ; Karlas, A.

Mapping glucose-induced hemodynamics in white fat depots with label-free optoacoustics.
In: (28th International Conference on Medical Image Computing and Computer Assisted Intervention, MICCAI 2025, 23-27 September 2025, Daejeon). Gewerbestrasse 11, Cham, Ch-6330, Switzerland: Springer International Publishing Ag, 2026. 653-662 (Lect. Notes Comput. Sc. ; 15961 LNCS)

Duelmer, F. ; Azampour, M.F. ; Wysocki, M. ; Navab, N.

UltraRay: Introducing Full-Path Ray Tracing in Physics-Based Ultrasound Simulation.
In: (4th Translational Biophotonics: Diagnostics and Therapeutics, 22-26 June 2025, Munich). 2025. (Proc. SPIE ; 13934)

Ricciardi, L. ; Rauschendorfer, P. ; Gorpas, D. ; Ntziachristos, V.

Importance of Distance Correction in Near-Infrared and Intravascular Ultrasound imaging for Reliable Assessment of the Cardiovascular Tissue Pathobiological State.
In: (4th Translational Biophotonics: Diagnostics and Therapeutics, 22-26 June 2025, Munich). 2025. (Proc. SPIE ; 13934)

Tenditnaya, A. ; Kriukova, E. ; Gabriëls, R.Y. ; Nagengast, W.B. ; Ntziachristos, V. ; Gorpas, D.

Influence of Sensitivity Metrics Definition on Fluorescence Molecular Endoscopy (FME) Systems Performance Assessment and Quality Control.
In: 22-26 June 2025 (4th Translational Biophotonics: Diagnostics and Therapeutics, Munich). 2025. (Proc. SPIE ; 13934)

Puttfarcken, B. ; Berger, C. ; Qiu, J. ; Pleitez, M.A.

Intravital Mid-Infrared Pump and Probe Detection of Metabolites.

Contact

Thomas Schwarz-Romond_freigestellt
Thomas Schwarz-Romond, PhD, MBA

Director of Operations, Helmholtz Pioneer Campus